Article
The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer
15 Jan 2014
Abstract excerpt
Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives many of the cancer 'hallmarks' through downstream activation of the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) signaling pathway. Additionally, dysregulation of the interleukin (IL)-6-mediated JAK/STAT3 signaling pathway is closely related to the development of diverse human solid tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
